Cargando…
Targeted delivery of thrombolytic enzymes
Although thrombolytic agents have been used for several decades in the treatment of thromboembolic conditions, there is an unmet need for the development of safer thrombolytic agents. The development of new molecules themselves may not be sufficient. This has sparked a growing interest in the design...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Tabriz University of Medical Sciences (TUOMS Publishing Group)
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022233/ https://www.ncbi.nlm.nih.gov/pubmed/33842278 http://dx.doi.org/10.34172/bi.2021.15 |